Intraoperative radiation therapy firm Intraop Medical posted financial results for its first quarter of 2006 (end-March 31), a period that company executives said marked the firm's transition from R&D into manufacturing.
For the period, Intraop posted revenues of $1.1 million, with a net loss of $1.8 million. For the first half of the year, revenues were $2.2 million, with an operating loss of $1.3 million and a net loss of $3.3 million.
The company markets the Mobetron system for delivering intraoperative radiation therapy (IORT) during cancer surgery.
By AuntMinnie.com staff writers
May 12, 2006
Related Reading
Intraop appoints Mestman, October 13, 2005
Intraop notches Polish Mobetron order, September 20, 2005
Intraop adds Italian install, September 12, 2005
Intraop raises $4.5 million, September 1, 2005
Intraop nets $3 million in financing, August 19, 2005
Copyright © 2006 AuntMinnie.com
